Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro

• Published in: Vascular pharmacology Vol. 146; p. 107110
• Main Authors: Lorusso, Bruno, Cerasoli, Giuseppe, Falco, Angela, Frati, Caterina, Graiani, Gallia, Madeddu, Denise, Nogara, Antonella, Corradini, Emilia, Roti, Giovanni, Cerretani, Elisa, Gherli, Andrea, Caputi, Mariafrancesca, Gnetti, Letizia, Pilato, Francesco Paolo, Quaini, Federico, Lagrasta, Costanza
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.10.2022
• Subjects: Atenolol; Autophagy; Cardiovascular; Endothelial cells; Infantile hemangioma; Metoprolol; Propranolol; Infantile hemangioma; Metoprolol; Propranolol; Atenolol; Autophagy; Endothelial cells
• ISSN: 1537-1891; 1879-3649; 1879-3649
• DOI: 10.1016/j.vph.2022.107110

The mechanisms underlying the success of propranolol in the treatment of infantile hemangioma (IH) remain elusive and do not fully explain the rapid regression of hemangiomatous lesions following drug administration. As autophagy is critically implicated in vascular homeostasis, we determined whether β-blockers trigger the autophagic flux on infantile hemangioma-derived endothelial cells (Hem-ECs) in vitro. Fresh tissue specimens, surgically removed for therapeutic purpose to seven children affected by proliferative IH, were subjected to enzymatic digestion. Cells were sorted with anti-human CD31 immunolabeled magnetic microbeads. Following phenotypic characterization, expanded Hem-ECs, at P2 to P6, were exposed to different concentrations (50 μM to 150 μM) of propranolol, atenolol or metoprolol alone and in combination with the autophagy inhibitor Bafilomycin A1. Rapamycin, a potent inducer of autophagy, was also used as control. Autophagy was assessed by Lysotracker Red staining, western blot analysis of LC3BII/LC3BI and p62, and morphologically by transmission electron microscopy. Hem-ECs treated with either propranolol, atenolol or metoprolol displayed positive LysoTracker Red staining. Increased LC3BII/LC3BI ratio, as well as p62 modulation, were documented in β-blockers treated Hem-ECs. Abundant autophagic vacuoles and multilamellar bodies characterized the cytoplasmic ultrastructural features of autophagy in cultured Hem-ECs exposed in vitro to β-blocking agents. Importantly, similar biochemical and morphologic evidence of autophagy were observed following rapamycin while Bafilomycin A1 significantly prevented the autophagic flux promoted by β-blockers in Hem-ECs. Our data suggest that autophagy may be ascribed among the mechanisms of action of β-blockers suggesting new mechanistic insights on the potential therapeutic application of this class of drugs in pathologic conditions involving uncontrolled angiogenesis. [Display omitted]